FDA to overhaul process for approving medical devices that some say puts consumers at risk

November 28, 2018

The Food and Drug Administration is overhauling the most common way medical device manufacturers bring their products to market in an attempt to advance new technologies.
Since 1976, manufacturers have been able to pursue an expedited approval process if they could prove new products were substantially equivalent to those that were grandfathered in when Congress established the pathway, known as 510(k).
Read more at CNBC >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Accepts Supplemental Biologics License Application for Botox Cosmetic for Masseter Muscle Prominence
    • Medical Spa Show Nominated for Best Tradeshow Injectable Education: 2026 L+A Clinical Collective Awards
    • Mango Voice Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • AmSpa Partners with Allergan Medical Institute to Offer Members Scholarship Opportunities
    • 27-Year-Old Dies Following NAD+ Infusion at New York Wellness Center